PRICE T ROWE ASSOCIATES INC /MD/ - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 315 filers reported holding EDITAS MEDICINE INC in Q4 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q3 2023$342
+16.3%
43,792
+22.7%
0.00%
Q2 2023$294
+15.3%
35,693
+1.7%
0.00%
Q1 2023$255
-4.9%
35,107
+16.1%
0.00%
Q4 2022$268
-99.9%
30,227
-12.7%
0.00%
Q3 2022$424,000
+16.5%
34,608
+12.5%
0.00%
Q2 2022$364,000
-23.5%
30,760
+23.0%
0.00%
Q1 2022$476,000
-24.0%
25,002
+6.1%
0.00%
Q4 2021$626,000
-64.5%
23,573
-45.1%
0.00%
Q3 2021$1,765,000
-19.4%
42,968
+11.2%
0.00%
Q2 2021$2,189,000
+63.1%
38,644
+20.9%
0.00%
Q1 2021$1,342,000
-29.0%
31,961
+18.6%
0.00%
Q4 2020$1,889,000
+355.2%
26,938
+82.3%
0.00%
Q3 2020$415,000
-94.1%
14,773
-94.9%
0.00%
-100.0%
Q1 2019$7,037,000
-41.1%
287,826
-45.2%
0.00%
-50.0%
Q4 2018$11,941,000
-51.4%
524,889
-32.1%
0.00%
-50.0%
Q3 2018$24,588,000
-12.5%
772,708
-1.4%
0.00%0.0%
Q2 2018$28,087,000
-5.1%
783,905
-12.2%
0.00%
-20.0%
Q1 2018$29,582,000
+7.2%
892,359
-0.6%
0.01%
+25.0%
Q4 2017$27,585,000
-7.0%
897,671
-27.3%
0.00%
-20.0%
Q3 2017$29,661,000
+21.0%
1,235,341
-15.4%
0.01%
+25.0%
Q2 2017$24,511,000
-21.7%
1,460,730
+4.2%
0.00%
-33.3%
Q1 2017$31,286,000
+18.1%
1,401,696
-14.1%
0.01%
+20.0%
Q4 2016$26,480,000
+4.8%
1,631,534
-13.0%
0.01%0.0%
Q3 2016$25,267,000
-24.5%
1,874,396
+32.5%
0.01%
-28.6%
Q2 2016$33,462,000
-29.1%
1,414,116
+0.3%
0.01%
-30.0%
Q1 2016$47,222,0001,409,8960.01%
Other shareholders
EDITAS MEDICINE INC shareholders Q4 2020
NameSharesValueWeighting ↓
NIA IMPACT ADVISORS, LLC 54,615$4,897,0002.55%
Capital Impact Advisors, LLC 130,000$9,114,0002.24%
ARK Investment Management 10,125,564$709,903,0001.89%
Nikko Asset Management Americas, Inc. 4,388,143$307,653,0001.75%
Spectrum Planning & Advisory Services Inc. 17,522$1,228,0001.32%
DDD Partners, LLC 79,527$5,576,0001.10%
Brevan Howard Capital Management LP 76,420$5,358,0001.08%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 538,721$37,770,0000.75%
DC Investments Management, LLC 3,627$254,0000.63%
Haafor (Singapore) Pte. Ltd. 4,761$334,0000.62%
View complete list of EDITAS MEDICINE INC shareholders